149 related articles for article (PubMed ID: 8722708)
21. Demonstration of human platelet beta-adrenergic receptors using 125I-labeled cyanopindolol and 125I-labeled hydroxybenzylpindolol.
Steer ML; Atlas D
Biochim Biophys Acta; 1982 Apr; 686(2):240-4. PubMed ID: 6282327
[TBL] [Abstract][Full Text] [Related]
22. Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells.
Calvo JR; Molinero P; Jimenez J; Goberna R; Guerrero JM
Peptides; 1986; 7(2):177-81. PubMed ID: 3016677
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of the beta-adrenergic receptor in the rat ventral prostate using [125I]cyanopindolol.
Poyet P; Gagne B; Lavoie M; Labrie F
Mol Cell Endocrinol; 1986 Nov; 48(1):59-67. PubMed ID: 2877909
[TBL] [Abstract][Full Text] [Related]
24. Receptors for vasoactive intestinal peptide on isolated epithelial cells of rat ventral prostate.
Prieto JC; Carmena MJ
Biochim Biophys Acta; 1983 Dec; 763(4):408-13. PubMed ID: 6317051
[TBL] [Abstract][Full Text] [Related]
25. Characterization of melatonin binding sites in the harderian gland and median eminence of the rat.
Lopez-Gonzalez MA; Calvo JR; Rubio A; Goberna R; Guerrero JM
Life Sci; 1991; 48(12):1165-71. PubMed ID: 1848342
[TBL] [Abstract][Full Text] [Related]
26. Beta-adrenergic receptors in DMBA-induced rat mammary tumors: correlation with progesterone receptor and tumor growth.
Marchetti B; Spinola PG; Plante M; Poyet P; Folléa N; Pelletier G; Labrie F
Breast Cancer Res Treat; 1989 Jul; 13(3):251-63. PubMed ID: 2569332
[TBL] [Abstract][Full Text] [Related]
27. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
28. Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric muscle cells.
Chijiiwa Y; Murthy KS; Grider JR; Makhlouf GM
Regul Pept; 1993 Sep; 47(3):223-32. PubMed ID: 8234906
[TBL] [Abstract][Full Text] [Related]
29. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE; Tatsuno I; Miyata A; Arimura A
Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
[TBL] [Abstract][Full Text] [Related]
30. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
[TBL] [Abstract][Full Text] [Related]
31. Characterization of functional receptors for vasoactive intestinal peptide in bovine cerebral arteries.
Suzuki Y; McMaster D; Huang M; Lederis K; Rorstad OP
J Neurochem; 1985 Sep; 45(3):890-9. PubMed ID: 2993516
[TBL] [Abstract][Full Text] [Related]
32. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors.
Patthi S; Simerson S; Veliçelebi G
J Biol Chem; 1988 Dec; 263(36):19363-9. PubMed ID: 2848823
[TBL] [Abstract][Full Text] [Related]
33. Effects of 2-hydroxyestradiol on the number of granulosa cell beta-adrenergic receptors.
Spicer LJ; Hammond JM
Endocrinology; 1988 Jun; 122(6):2710-7. PubMed ID: 2836172
[TBL] [Abstract][Full Text] [Related]
34. Characterization of vasoactive intestinal peptide receptors in rabbit ciliary processes.
Horio B; Law NM; Rosenzweig SA
Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):192-9. PubMed ID: 7529752
[TBL] [Abstract][Full Text] [Related]
35. Identification of the subunit structure of rat pineal adrenergic receptors by photoaffinity labeling.
Dickinson KE; Leeb-Lundberg LM; Strasser RH; Caron MG; Lefkowitz RJ
J Neurochem; 1986 Apr; 46(4):1153-60. PubMed ID: 3005506
[TBL] [Abstract][Full Text] [Related]
36. Response and level of beta-adrenergic, vasoactive intestinal peptide, and PACAP receptors during the circadian cycle.
Hirota A; Kiuchi Y; Nii H; Gregory DS
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1708-18. PubMed ID: 9286259
[TBL] [Abstract][Full Text] [Related]
37. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS
Peptides; 1986; 7(5):791-800. PubMed ID: 3025822
[TBL] [Abstract][Full Text] [Related]
38. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
[TBL] [Abstract][Full Text] [Related]
39. Autoradiographic mapping of [mono[125I]iodo-Tyr10, MetO17]vasoactive intestinal peptide binding sites in the rat brain.
Martin JL; Dietl MM; Hof PR; Palacios JM; Magistretti PJ
Neuroscience; 1987 Nov; 23(2):539-65. PubMed ID: 3437978
[TBL] [Abstract][Full Text] [Related]
40. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells.
Frucht H; Gazdar AF; Park JA; Oie H; Jensen RT
Cancer Res; 1992 Mar; 52(5):1114-22. PubMed ID: 1310640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
